Skip to content
Governance Register

← US public companies

Mahatme Sandesh

SEC-identified person · CIK 1511034 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Crispr Therapeutics AG CRSP Director filed 2024–2026
Vor Biopharma Inc. VOR CFO filed 2025–2025
Spyre Therapeutics, Inc. SYRE Director filed 2016–2022
Sarepta Therapeutics, Inc. SRPT Senior Vice President, CFO filed 2012–2020
Flexion Therapeutics Inc FLXN Director filed 2014–2020
Stalar 4, Inc. N/A Director · Treasurer filed 2011–2011
Stalar 3 Inc. N/A Director · Treasurer filed 2011–2011

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.